
    
      A Single Center, Randomized, Double-blinded, Placebo-controlled, Open-label,
      Positive-controlled, Four-way Crossover Study to Assess the Effect of a Single Oral Dose
      NKTR-118 Administration on QTc Interval Compared to Placebo, Using AVELOX (moxifloxacin) as a
      Positive Control, in Healthy Male Subjects
    
  